Stig Palm
-
Realizing Clinical Trials with Astatine-211: The Chemistry
Infrastructure
Sture Lindegren, Per Albertsson, Tom Bäck, H. Jensen, Stig Palm, Emma Aneheim
Cancer Biotherapy and Radiopharmaceuticals - 2020-01-01 -
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone
microtumors
Tom Bäck, Karin Jennbacken, Malin Hagberg Thulin, Sture Lindegren, H. Jensen, T. Olafsen, P. J. Yazaki, Stig Palm, Per Albertsson, Jan-Erik Damber, A. M. Wu, Karin Welén
Ejnmmi Research - 2020-01-01 -
Intraperitoneal alpha-Emitting Radioimmunotherapy with At-211 in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose
Estimations
Andreas Hallqvist, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, H. Jensen, Lars Jacobsson, Ragnar Hultborn, Stig Palm, Per Albertsson
Journal of Nuclear Medicine - 2019-01-01 -
Towards elucidating the radiochemistry of astatine - Behavior in
chloroform
Emma Aneheim, Stig Palm, H. Jensen, C. Ekberg, Per Albertsson, Sture Lindegren
Scientific Reports - 2019-01-01 -
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo
Behavior
Y. Dekempeneer, Tom Bäck, Emma Aneheim, H. Jensen, J. Puttemans, C. Xavier, M. Keyaerts, Stig Palm, Per Albertsson, T. Lahoutte, V. Caveliers, Sture Lindegren, M. D'Huyvetter
Molecular Pharmaceutics - 2019-01-01 -
Radiosensitivity: Gender and Order of Administration of G-CSF, An Experimental Study in
Mice
Ragnar Hultborn, Per Albertsson, Susanne Ottosson, Elisabet Warnhammar, Åsa Palm, Stig Palm, Kerstin Elmroth
Radiation Research - 2019-01-01 -
Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and
meta-analysis
Per Albertsson, Charlotte Alverbratt, Ann Liljegren, Emil Björkander, Annika Strandell, Ola Samuelsson, Stig Palm, Andreas Hallqvist
Critical reviews in oncology/hematology - 2018-01-01 -
Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor
Sizes.
Stig Palm, Tom Bäck, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2018-01-01 -
Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated alpha-Radioimmunotherapy with At-211-MX35-F(ab')(2): Influence of Absorbed Tumor Dose and Effect on Long-Term
Survival
Tom Bäck, N. Chouin, Sture Lindegren, Helena Kahu, H. Jensen, Per Albertsson, Stig Palm
Journal of Nuclear Medicine - 2017-01-01 -
Therapeutic efficacy of alpha-radioimmunotherapy with different activity levels of the Bi-213-labeled monoclonal antibody MX35 in an ovarian cancer
model
Anna Gustafsson-Lutz, Tom Bäck, Emma Aneheim, Ragnar Hultborn, Stig Palm, Lars Jacobsson, A. Morgenstern, F. Bruchertseifer, Per Albertsson, Sture Lindegren
EJNMMI Research - 2017-01-01 -
Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide
Immunoconjugates
Emma Aneheim, Anna Gustafsson, Per Albertsson, Tom Bäck, Holger Jensen, Stig Palm, Sofia Svedhem, Sture Lindegren
Bioconjugate chemistry - 2016-01-01 -
Biokinetic modeling and dosimetry for optimizing intraperitoneal radioimmunotherapy of ovarian cancer
microtumors.
Stig Palm, Tom Bäck, Börje Haraldsson, Lars Jacobsson, Sture Lindegren, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2016-01-01 -
Nuclear Medicine Physics - a handbook for teachers and
students.
Stig Palm, GL Poli
- 2015-01-01 -
MIRD - Radiobiology and dosimetry for radiopharmaceutical therapy with alpha-particle
emitters.
G Sgouros, Stig Palm
- 2015-01-01 -
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer
Patients.
Elin Cederkrantz, Håkan Andersson, Peter Bernhardt, Thomas Backhaus, Ragnar Hultborn, Lars Jacobsson, Holger Jensen, Sture Lindegren, Michael Ljungberg, Tobias Magnander, Stig Palm, Per Albertsson
International journal of radiation oncology, biology, physics - 2015-01-01 -
Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version
Rebmab200.
Sture Lindegren, Luciana N S Andrade, Tom Bäck, Camila Maria L Machado, Bruno Brasil Horta, Carlos Buchpiguel, Ana Maria Moro, Oswaldo Keith Okamoto, Lars Jacobsson, Elin Cederkrantz, Kohshin Washiyama, Emma Aneheim, Stig Palm, Holger Jensen, Maria Carolina B Tuma, Roger Chammas, Ragnar Hultborn, Per Albertsson
PloS one - 2015-01-01 -
Automated astatination of biomolecules--a stepping stone towards multicenter clinical
trials.
Emma Aneheim, Per Albertsson, Tom Bäck, Holger Jensen, Stig Palm, Sture Lindegren
Scientific reports - 2015-01-01 -
PET/CT atlas on quality Control and image artefacts. Human Health series no.
27.
Stig Palm, GL Poli, H Delis
- 2014-01-01 -
Quantitative Nuclear Medicine Imaging: Concepts, Requirements and Methods. Human Health Reports
#9.
Stig Palm, GL Poli
- 2014-01-01 -
Ex Vivo Activity Quantification in Micrometastases at the Cellular Scale Using the α-Camera
Technique.
Nicolas Chouin, Sture Lindegren, Sofia Frost, Holger Jensen, Per Albertsson, Ragnar Hultborn, Stig Palm, Lars Jacobsson, Tom Bäck
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2013-01-01 -
Clinical Training of Medical Physicists Specializing in Nuclear Medicine. Training Course Series No. 50. ISSN
1018-5518.
D McLean, Stig Palm, MP Dias
- 2011-01-01 -
Patient-specific alpha-particle
dosimetry
Stig Palm, Jörgen Elgqvist, Lars Jacobsson
Current radiopharmaceuticals - 2011-01-01 -
Results of an international comparison of
57Co.
B E Zimmerman, Stig Palm
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine - 2010-01-01 -
Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic
cancer.
Stavroula Sofou, Richard Enmon, Stig Palm, Barry Kappel, Pat Zanzonico, Michael R McDevitt, David A Scheinberg, George Sgouros
Journal of liposome research - 2010-01-01 -
Planning a Clinical PET Centre. Human Health Series No.
11
M Dondi, Stig Palm, M Haji-Saied
- 2010-01-01 -
MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide
therapy.
George Sgouros, John C Roeske, Michael R McDevitt, Stig Palm, Barry J Allen, Darrell R Fisher, A Bertrand Brill, Hong Song, Roger W Howell, Gamal Akabani
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2010-01-01 -
Ovarian cancer: background and clinical
perspectives
Jörgen Elgqvist, Ragnar Hultborn, Sture Lindegren, Stig Palm
Targeted Radionuclide Therapy - 2010-01-01 -
Quality Assurance for SPECT systems. Human Health Series No.
6.
M Dondi, Stig Palm
- 2009-01-01 -
Quality Assurance for PET and PET/CT Systems. Human Health Series No.
1.
M Dondi, D McLean, Stig Palm
- 2009-01-01 -
MIRD Pamphlet No. 22 - Radiobiology and Dosimetry of Alpha-particle Emitters for Targeted Radionuclide
Therapy.
G Sgouros, JC Roeske, MR McDevitt, Stig Palm, BJ Allen, DR Fisher, AB Brill, H Song, RW Howell, G Akabani
- 2009-01-01 -
Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I
study.
Håkan Andersson, Elin Cederkrantz, Tom Bäck, Chaitanya Divgi, Jörgen Elgqvist, Jakob Himmelman, György Horvath, Lars Jacobsson, Holger Jensen, Sture Lindegren, Stig Palm, Ragnar Hultborn
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2009-01-01 -
Differences in radiosensitivity between three HER2 overexpressing cell
lines.
Ann-Charlott Steffen, Lovisa Göstring, Vladimir Tolmachev, Stig Palm, Bo Stenerlöw, Jörgen Carlsson
European journal of nuclear medicine and molecular imaging - 2008-01-01 -
Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude
mice.
Stig Palm, Tom Bäck, Ingela Claesson, Anna Danielsson, Jörgen Elgqvist, Sofia Frost, Ragnar Hultborn, Holger Jensen, Sture Lindegren, Lars Jacobsson
International journal of radiation oncology, biology, physics - 2007-01-01 -
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35
F(ab')2.
Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt, Tom Bäck, Ingela Claesson, Ragnar Hultborn, Holger Jensen, Bengt R Johansson, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
International journal of radiation oncology, biology, physics - 2006-01-01 -
Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed
dose.
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ingela Claesson, Ragnar Hultborn, Holger Jensen, Bengt R Johansson, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2006-01-01 -
Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and
myelotoxicity
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ingela Claesson, Ragnar Hultborn, H. Jensen, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
Nucl Med Biol - 2006-01-01 -
Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody
MX35
Jörgen Elgqvist, Håkan Andersson, Tom Bäck, Ragnar Hultborn, H. Jensen, Börje Karlsson, Sture Lindegren, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
J Nucl Med - 2005-01-01 -
211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in
vivo
Tom Bäck, Håkan Andersson, C. R. Divgi, Ragnar Hultborn, H. Jensen, Sture Lindegren, Stig Palm, Lars Jacobsson
J Nucl Med - 2005-01-01 -
Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu
expression.
Ase M Ballangrud, Wei-Hong Yang, Stig Palm, Richard Enmon, Paul E Borchardt, Virginia A Pellegrini, Michael R McDevitt, David A Scheinberg, George Sgouros
Clinical cancer research : an official journal of the American Association for Cancer Research - 2004-01-01 -
Microdosimetry of astatine-211 single-cell irradiation: role of daughter polonium-211
diffusion.
Stig Palm, John L Humm, Robert Rundqvist, Lars Jacobsson
Medical physics - 2004-01-01 -
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and
MRI.
Stig Palm, Richard M Enmon, Cornelia Matei, Katherine S Kolbert, Su Xu, Pat B Zanzonico, Ronald L Finn, Jason A Koutcher, Steven M Larson, George Sgouros
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2003-01-01 -
Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor
model
Håkan Andersson, Jörgen Elgqvist, György Horvath, Ragnar Hultborn, Lars Jacobsson, H. Jensen, Börje Karlsson, Sture Lindegren, Stig Palm
Clin Cancer Res - 2003-01-01 -
Single-cell irradiation from [211At] astatine-labeled C215 monoclonal antibody: improved estimates of radiosensitivity from measurements on cellular uptake and
retention
Stig Palm, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Sture Lindegren, Lars Jacobsson
Anticancer Res - 2003-01-01 -
Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian
cancer.
Håkan Andersson, Stig Palm, Sture Lindegren, Tom Bäck, Lars Jacobsson, Gunilla Leser, György Horvath
Anticancer research - 2001-01-01 -
Dosimetrical considerations in astatine-211
radioimmunotherapy
Stig Palm, Lars Jacobsson
Therapeutic applications of radiopharmaceuticals. IAEA-TECDOC-1228 - 2001-01-01 -
In vitro effects of free 211At,211At-albumin and 211At-monoclonal antibody compared to external photon irradiation on two human cancer cell
lines
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 2000-01-01 -
Cell growth kinetics of the human cell line Colo-205 irradiated with photons and astatine-211
alpha-particles
Stig Palm, Håkan Andersson, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 2000-01-01 -
Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth
assay
Stig Palm, Tom Bäck, Ingela Claesson, Ulla Delle, Ragnar Hultborn, Lars Jacobsson, Istvan Köpf, Sture Lindegren
Anticancer Res - 1998-01-01